Database Registry of the Intermountain Heart Collaborative Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00406185|
Recruitment Status : Active, not recruiting
First Posted : December 4, 2006
Last Update Posted : November 4, 2019
|Condition or disease|
|Coronary Artery Disease Electrophysiology Cardiovascular Disease|
This is a registry (database) project; there are no investigational treatments, drug or procedures associated with participation in registry activities. This project is an organized data gathering and storing (database) endeavor with specific focus on the precursors, modifiers, biological, and genetic parameters of heart disease and related medical conditions. Data collection will not immediately influence the course of treatment for any patient.Sample testing and data utilization for basic science, clinical, and epidemiologic and publication projects can be initiated using the databank.
The registry will enable researchers to determine best medical practices for predicting, preventing, and treating heart disease. The registry will: 1) develop standard methods to collect data and specimens which will be used for research to characterize patients diagnosed with heart disease as well as healthy controls and to assess differences in demographics and patient outcomes in both populations; 2) collect, process, and store patients' clinical data and tissue/blood samples; 3) analyze data collected; 4) use these resources to identify genes, genetic polymorphisms, genetic mutations, clinical methods and procedures, and/or biomarkers that predict, prevent, or treat heart disease and/or are associated correlate with lifestyle or disease outcomes; 5) publish and disseminate results.
|Study Type :||Observational|
|Estimated Enrollment :||30000 participants|
|Official Title:||Database Registry of the Intermountain Heart Collaborative Study|
|Study Start Date :||October 1994|
|Estimated Primary Completion Date :||January 2024|
|Estimated Study Completion Date :||January 2024|
- Outcome Risk [ Time Frame: 30 years ]To evaluate risk factors, characteristics, and treatments to cardiovascular outcomes
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00406185
|United States, Utah|
|Intermountain Medical Center|
|Murray, Utah, United States, 84157|
|Principal Investigator:||Joseph B Muhlestein, MD||Intermountain Healthcare, LDS Hospital|